BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 7629227)

  • 1. Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma.
    Cavaco B; Leite V; Santos MA; Arranhado E; Sobrinho LG
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2342-6. PubMed ID: 7629227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of big, big prolactin in patients with hyperprolactinaemia.
    Leite V; Cosby H; Sobrinho LG; Fresnoza MA; Santos MA; Friesen HG
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):365-72. PubMed ID: 1483294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneously occurring anti-PTH autoantibodies must be considered in the differential diagnosis of patients with elevated serum PTH levels.
    Cavaco B; Leite V; Loureiro MM; Ferreira MF; Pereira MC; Santos MA; Sobrinho LG
    J Endocrinol Invest; 1999 Dec; 22(11):829-34. PubMed ID: 10710269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular heterogeneity of prolactin and gonadotropins in some forms of sterility].
    Morán C; Fonseca ME; Ochoa R; Masón M; Gama R; Zárate A
    Ginecol Obstet Mex; 1990; 58 Suppl 1():9-13. PubMed ID: 2125965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
    Hattori N; Inagaki C
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
    Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
    Hattori N
    J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
    De Schepper J; Schiettecatte J; Velkeniers B; Blumenfeld Z; Shteinberg M; Devroey P; Anckaert E; Smitz J; Verdood P; Hooghe R; Hooghe-Peters E
    Eur J Endocrinol; 2003 Sep; 149(3):201-7. PubMed ID: 12943522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical method for the detection of macroprolactinaemia using ultrafiltration.
    Prazeres S; Santos MA; Ferreira HG; Sobrinho LG
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):686-90. PubMed ID: 12780743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of macroprolactinemia in the differential diagnosis of hyperprolactinemic patients.
    Bağdatoğlu C; Bağdatoğlu OT; Muslu N; Köseoğlu A; Dağtekin A; Polat G; Dolgun H; Karataş MA
    Turk Neurosurg; 2008 Jul; 18(3):223-7. PubMed ID: 18814107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
    Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of pituitary adenomas in macroprolactinemic patients may be higher than it is presumed.
    Tamer G; Telci A; Mert M; Uzum AK; Aral F; Tanakol R; Yarman S; Boztepe H; Colak N; Alagöl F
    Endocrine; 2012 Feb; 41(1):138-43. PubMed ID: 21959531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of macroprolactin in the form of prolactin-immunoglobulin G complexes by immunoprecipitation with anti-human IgG-agarose.
    Schiettecatte J; De Schepper J; Velkeniers B; Smitz J; Van Steirteghem A
    Clin Chem Lab Med; 2001 Dec; 39(12):1244-8. PubMed ID: 11798085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactinaemia associated with prolactin adenoma.
    Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
    Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
    Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
    Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macroprolactin in subjects with hyperprolactinaemia: clinical observations and relations between free PRL and PRL complexed with IgG].
    Jeske W; Zgliczyński W; Gorzelak K
    Endokrynol Pol; 2005; 56(5):779-84. PubMed ID: 16817144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.